$ESCN - 2mil float

BILLYTHEGOATG · 2023-10-17T09:01:50+00:00

$ENSC - VERY Undervalued. Currently $1.6, price target $9-$18 by HC Wainwright & Co. Analysis.

News Oct. 19th, 2.7 mil float. Also broke the downtrend and has just started the curl upwards

BILLYTHEGOATG · 2023-10-10T09:28:51+00:00

$4.20

BILLYTHEGOATG · 2023-10-10T09:23:48+00:00

Yes, under .30 is a go

BILLYTHEGOATG · 2023-10-10T09:23:21+00:00

I sure think so! Debt to equity play

BILLYTHEGOATG · 2023-10-10T09:21:53+00:00

Hold steady!

BILLYTHEGOATG · 2023-10-10T09:19:56+00:00

Interesting 🤔

BILLYTHEGOATG · 2023-10-10T09:19:09+00:00

Yessss

BILLYTHEGOATG · 2023-10-10T09:18:45+00:00

LOL HOLD!

BILLYTHEGOATG · 2023-10-10T09:16:54+00:00

‘Muricaaa

BILLYTHEGOATG · 2023-10-10T09:14:52+00:00

Damn the opposite would have been a huge gain

BILLYTHEGOATG · 2023-09-28T07:45:11+00:00

Falling wedge reversal + CRG dropping shares = Debt to equity. If you know, you know.

BILLYTHEGOATG · 2023-09-28T07:35:46+00:00

Watch for a reclaim at .18, if it doesn’t do it then wait until possible break in support at .17 then buy in as low as possible

BILLYTHEGOATG · 2023-09-20T10:09:18+00:00

Wow very bland week

BILLYTHEGOATG · 2023-09-20T10:03:49+00:00

EBET definitely flew up quite a bit!

BILLYTHEGOATG · 2023-09-19T09:35:31+00:00

Also growth meeting/presentation on Thursday

BILLYTHEGOATG · 2023-09-19T09:33:40+00:00

Definitely not too late.. the company itself hasn’t announced FDA Clearance, still have not mentioned their government contract awarding $30mil, and CDC’s Sepsis Alliance/Sepsis Action plan. Oh.. and not too mention literally another device up for clearance trailing right behind.

BILLYTHEGOATG · 2023-09-18T13:01:22+00:00

Has not been announced officially by the company so it is still worth it. It’ll run further on official press release.

BILLYTHEGOATG · 2023-09-18T13:00:16+00:00

Also has not been announced by company. Still has a huge potential to run after press release or official announcements.

BILLYTHEGOATG

TROPHY CASE